Stockscreener 앱 받기
2.1162
6.88%
0.1362
시장 영업 전:
2.11
-0.0062
-0.29%
전일 마감가:
$1.98
열려 있는:
$1.9701
하루 거래량:
168.68K
Relative Volume:
0.15
시가총액:
$6.92M
수익:
-
순이익/손실:
$-8.26M
주가수익비율:
-0.0395
EPS:
-53.609
순현금흐름:
$-12.17M
1주 성능:
+6.88%
1개월 성능:
+26.72%
6개월 성능:
+45.94%
1년 성능:
-81.67%
1일 변동 폭
$1.9563
$2.1497
1주일 범위
$1.77
$2.1497
52주 변동 폭
$1.10
$16.91
Gri Bio Inc Stock (GRI) Company Profile
명칭
Gri Bio Inc
전화
(619) 400-1171
주소
2223 AVENIDA DE LA PLAYA, LA JOLLA
GRI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GRI
Gri Bio Inc
|
2.1162 | 6.47M | 0 | -8.26M | -12.17M | -53.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gri Bio Inc Stock (GRI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-09 | 개시 | H.C. Wainwright | Buy |
Gri Bio Inc 주식(GRI)의 최신 뉴스
Why GRI Bio Inc. stock is seen as undervaluedSell Signal & Weekly Return Optimization Alerts - Newser
GRI Bio receives Nasdaq notice for non-compliance with equity listing rule - Investing.com Australia
GRI Bio (GRI) Stock Analysis Report | Financials & Insights - Benzinga
GRI Bio Inc. (GRI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What insider trading reveals about GRI Bio Inc. stockWeekly Gains Summary & Long-Term Safe Investment Ideas - BỘ NỘI VỤ
Stop Loss: What sentiment indicators say about GRI Bio Inc. stock2025 Retail Activity & Long-Term Growth Portfolio Plans - moha.gov.vn
Buy Signal: What insider trading reveals about GRI Bio Inc. stock2025 Technical Overview & Low Risk Profit Maximizing Plans - moha.gov.vn
This trade activity should not be overlooked: GRI Bio Inc (GRI) - Setenews
Wall Street analysts’ outlook for Moolec Science SA (MLEC) - Setenews
GRI Bio Inc Stock Analysis and ForecastRisk Mitigation Techniques & Rapid Capital Appreciation - earlytimes.in
GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ('IPF') - ADVFN
GRI Stock Price and Chart — NASDAQ:GRI - TradingView
The growth track for GRI Bio Inc (GRI) has changed recently - Setenews
What technical charts say about GRI Bio Inc. stock2025 Price Action Summary & Weekly Setup with High ROI Potential - newser.com
How GRI Bio Inc. stock benefits from strong dollarShare Buyback & Free Daily Entry Point Trade Alerts - newser.com
GRI Bio Inc. stock daily chart insightsWeekly Investment Report & Low Drawdown Momentum Ideas - newser.com
Visual analytics tools that track GRI Bio Inc. performanceBond Market & Reliable Price Breakout Signals - newser.com
How supply chain issues affect GRI Bio Inc. stock2025 Top Decliners & Daily Profit Focused Screening - newser.com
Will GRI Bio Inc. stock see insider buyingMarket Growth Summary & Free High Accuracy Swing Entry Alerts - newser.com
Using economic indicators to assess GRI Bio Inc. potentialInsider Selling & Technical Pattern Based Buy Signals - newser.com
Will GRI Bio Inc. stock outperform value stocksJuly 2025 Review & Real-Time Market Sentiment Alerts - newser.com
Technical analysis overview for GRI Bio Inc. stockJuly 2025 Opening Moves & Safe Entry Zone Tips - newser.com
What does recent volatility data suggest for GRI Bio Inc.Quarterly Trade Summary & Verified Short-Term Plans - newser.com
GRI SEC FilingsGRI Bio 10-K, 10-Q, 8-K Forms - Stock Titan
GRI Q3 2025 Earnings Report on 11/14/2025 - MarketBeat
GRI Bio, Inc. SEC 10-Q Report - TradingView
Form 424B3 GRI Bio, Inc. - StreetInsider
GRI: Net loss rose to $9.3M YTD; cash runway extends into Q1 2026, but funding uncertainty remains - TradingView
GRI Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Analyzing net buyer seller activity in GRI Bio Inc.2025 Short Interest & Intraday High Probability Setup Alerts - newser.com
Gri Bio Inc (GRI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.10%
1.10%
자본화:
|
볼륨(24시간):